Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05399381 · ClinicalTrials.gov registry record · NA

Traveling-wave Transcranial Electric Stimulation

A NA study of Working Memory, sponsored by University of Minnesota.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05399381: Active NA study of Working Memory, sponsored by University of Minnesota.

NCT05399381 is a NA study of Working Memory that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 30 participants, below the 62-participant average among 5 other Working Memory trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05399381, a NA study of Working Memory, is active but no longer recruiting, sponsored by University of Minnesota.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study will assess the impact of traveling wave transcranial alternating current stimulation (tACS) on working memory performance in adults.

Primary Outcome

Accuracy (proportion of correct responses) during performance of the N-back working memory task within each stimulation block. Values represent absolute task performance during active or sham stimulation in a within-subject crossover design.

Conditions Studied

Interventions

  • DEVICE Transcranial alternating current stimulation (tACS)

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-09-05
Est. Completion 2026-02-01
Phase NA
University of Minnesota

966 total trials

What the registry record for NCT05399381 still lists

NCT05399381 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 62-participant average among 5 other Working Memory trials with a reported enrollment target (52% lower).

The record links to 1 condition, with Working Memory appearing as the primary indexed condition, and to 1 intervention - of which Transcranial alternating current stimulation (tACS) is the first listed.

NCT05399381 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05399381 about?

NCT05399381 is a clinical study titled "Traveling-wave Transcranial Electric Stimulation". This study will assess the impact of traveling wave transcranial alternating current stimulation (tACS) on working memory performance in adults.

What is the current status of trial NCT05399381?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-09-05. Estimated completion is 2026-02-01.

What conditions does trial NCT05399381 study?

This clinical trial studies the following conditions: Working Memory.

What interventions are being tested in trial NCT05399381?

The interventions under investigation include: Transcranial alternating current stimulation (tACS) (DEVICE).

Who is sponsoring clinical trial NCT05399381?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05399381 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Working Memory

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05399381, the US trial registry maintained by the National Library of Medicine. NCT05399381 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.